首页> 外文期刊>Endocrine journal >Establishment of diagnosis by bisulfite-treated methylation- specific PCR method and analysis of clinical characteristics of pseudohypoparathyroidism type lb
【24h】

Establishment of diagnosis by bisulfite-treated methylation- specific PCR method and analysis of clinical characteristics of pseudohypoparathyroidism type lb

机译:亚硫酸氢盐处理的甲基化特异性PCR方法诊断的建立及假性甲状旁腺功能减退症的临床特征分析

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract. Pathogenesis of pseudohypoparathyroidism type lb (PHP-lb) is related to the loss of methylation at the GNAS exon A/B region, which is combined with epigenetic defects at other differentially methylated GNAS regions in most sporadic cases. In this study, we established a method for evaluating the methylation status of a CpG island in exon A/B using a methylation-specific polymerase chain reaction (MSPCR). We designed two primer pairs specific for the methylated and unmethylated alleles and evaluated the methylation status of GNAS exon A/B in samples from PHP-lb patients and normal controls. We examined 20 Japanese patients and 20 normal controls, and one primer set was found to be appropriate for diagnosis. Furthermore, we evaluated the clinical data of patients. Weight and height of patients were not significantly different from the normal population. Short stature (adult height < 2SD) was observed in one patient and short metacarpals in two. Obesity was observed in six patients, and no patient showed ectopic subcutaneous calcification. Seven patients showed subclinical hypothyroidism because of resistance to thyroid stimulating hormone, but no patient had an abnormally low free thyroxine level, and none received oral thyroid hormone replacement. For diagnosis of PHP-lb, only clinical data is not sufficient because a few PHP-lb patients show clinical features similar to PHP-la, and hence, molecular biology techniques are required for correct diagnosis. We concluded that MSPCR is applicable for rapid molecular diagnosis of PHP-lb.
机译:抽象。 lb型假性甲状旁腺功能减退症的发病机制与GNAS外显子A / B区甲基化的丧失有关,在大多数情况下,这与其他差异甲基化的GNAS区的表观遗传缺陷有关。在这项研究中,我们建立了一种使用甲基化特异性聚合酶链反应(MSPCR)评估外显子A / B中CpG岛的甲基化状态的方法。我们设计了两个分别对甲基化和未甲基化等位基因具有特异性的引物对,并评估了来自PHP-1b患者和正常对照的样品中GNAS外显子A / B的甲基化状态。我们检查了20名日本患者和20名正常对照,发现一套引物适合诊断。此外,我们评估了患者的临床数据。患者的体重和身高与正常人群无明显差异。在一名患者中观察到身材矮小(成人身高<2SD),在两名患者中观察到了短掌骨。在六名患者中观察到肥胖,并且没有患者显示异位皮下钙化。 7名患者由于对甲状腺刺激激素的抵抗性而表现出亚临床甲状腺功能减退,但没有患者的游离甲状腺素水平异常低,并且均未接受口服甲状腺激素替代治疗。对于PHP-1b的诊断,仅临床数据是不够的,因为一些PHP-1b的患者表现出与PHP-1a相似的临床特征,因此,需要分子生物学技术来进行正确的诊断。我们得出结论,MSPCR适用于PHP-1b的快速分子诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号